172 related articles for article (PubMed ID: 15841314)
1. Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia.
Ames PR; Ciampa A; Margaglione M; Scenna G; Iannaccone L; Brancaccio V
Thromb Haemost; 2005 Apr; 93(4):694-9. PubMed ID: 15841314
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study.
Hering D; Piper C; Bergemann R; Hillenbach C; Dahm M; Huth C; Horstkotte D
Chest; 2005 Jan; 127(1):53-9. PubMed ID: 15653962
[TBL] [Abstract][Full Text] [Related]
3. Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome.
Ames PR; Margaglione M; Ciampa A; Colaizzo D; Ferrara F; Iannaccone L; Vincenzobrancaccio
Thromb Res; 2011 Jun; 127(6):595-9. PubMed ID: 21371740
[TBL] [Abstract][Full Text] [Related]
4. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
[TBL] [Abstract][Full Text] [Related]
5. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
6. Achieved anticoagulation vs prosthesis selection for mitral mechanical valve replacement: a population-based outcome study.
Le Tourneau T; Lim V; Inamo J; Miller FA; Mahoney DW; Schaff HV; Enriquez-Sarano M
Chest; 2009 Dec; 136(6):1503-1513. PubMed ID: 19482955
[TBL] [Abstract][Full Text] [Related]
7. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
[TBL] [Abstract][Full Text] [Related]
9. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
10. Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.
Garcia CB; Seguro LP; Perandini LA; de Sá Pinto AL; Lima FR; Negrão CE; Bonfa E; Borba EF
Rheumatol Int; 2014 Dec; 34(12):1737-41. PubMed ID: 24825252
[TBL] [Abstract][Full Text] [Related]
11. [Severe, non-infectious mitral valve endocarditis after mitral valve reconstruction in a 32-year old female with primary antiphospholipid syndrome].
Herrmann M; Keysser G; Seige M; Holzhausen HJ; Silber RE; Diez C
Z Kardiol; 2004 Jul; 93(7):546-54. PubMed ID: 15243766
[TBL] [Abstract][Full Text] [Related]
12. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.
Torella M; Torella D; Chiodini P; Franciulli M; Romano G; De Santo L; De Feo M; Amarelli C; Sasso FC; Salvatore T; Ellison GM; Indolfi C; Cotrufo M; Nappi G
Am Heart J; 2010 Jul; 160(1):171-8. PubMed ID: 20598989
[TBL] [Abstract][Full Text] [Related]
13. North American multicenter experience with the On-X prosthetic heart valve.
McNicholas KW; Ivey TD; Metras J; Szentpetery S; Marra SW; Masters RG; Dilling EW; Slaughter MS; Mack MJ
J Heart Valve Dis; 2006 Jan; 15(1):73-8; discussion 79. PubMed ID: 16480015
[TBL] [Abstract][Full Text] [Related]
14. Thrombo-embolic and bleeding complications in patients with mechanical valve replacements--a prospective observational study.
Schapkaitz E; Jacobson BF; Becker P; Conway G
S Afr Med J; 2006 Aug; 96(8):710-3. PubMed ID: 17019493
[TBL] [Abstract][Full Text] [Related]
15. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.
Hernández-Molina G; Espericueta-Arriola G; Cabral AR
Clin Exp Rheumatol; 2013; 31(3):382-8. PubMed ID: 23305633
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
[TBL] [Abstract][Full Text] [Related]
17. [Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation].
Kanaoka Y; Tanemoto K; Murakami T; Kuroki K
Kyobu Geka; 2000 Aug; 53(9):754-8. PubMed ID: 10935402
[TBL] [Abstract][Full Text] [Related]
18. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
[TBL] [Abstract][Full Text] [Related]
19. Aniticoagulation in patients following prosthetic heart valve replacement.
Akhtar RP; Abid AR; Zafar H; Khan JS
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
[TBL] [Abstract][Full Text] [Related]
20. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement.
Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R
Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
